1. PO-1351 Patterns of local relapse following tumor-targeted dose escalation for localized prostate cancer. (August 2021) Authors: Padayachee, J.; Sanmamed, N.; Lee, J.; Liu, Z.; Berlin, A.; Craig, T.; Lao, B.; Rink, A.; Bayley, A.; Catton, C.; Sundaramurthy, A.; Foltz, W.; McPartlin, A.; Ghai, S.; Atenafu, E.; Gospodarowicz, M.; Warde, P.; Helou, J.; Raman, S.; Ménard, C. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PV-0147 MRI-guided salvage HDR brachytherapy for locally recurrent prostate cancer. (April 2019) Authors: Joseph, L.; Sundaramurthy, A.; Berlin, A.; Helou, J.; Menard, C.; Warde, P.; Catton, C.; Lao, B.; Bayley, A.; Rink, A.; Beiki-Ardakani, A.; Chung, P. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PV-0258: Dose to the Bladder Neck: Impact on Urinary Toxicity after MRI-guided HDR Prostate Brachytherapy. (April 2018) Authors: Sanmamed, N.; Chung, P.; Berlin, A.; Borg, J.; Lao, B.; Weersink, R.; Simeonov, A.; Rink, A.; Menard, C.; Helou, J. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗